Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/36968
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorCOSTA, Annielson de Souza
dc.contributor.authorGOMES, Jessica Menezes
dc.contributor.authorGERMANI, Ana Claudia Camargo Goncalves
dc.contributor.authorSILVA, Matheus Reis da
dc.contributor.authorSANTOS, Edige Felipe de Sousa
dc.contributor.authorSOARES JUNIOR, Jose Maria
dc.contributor.authorBARACAT, Edmund Chada
dc.contributor.authorSORPRESO, Isabel Cristina Esposito
dc.date.accessioned2020-08-20T13:25:08Z-
dc.date.available2020-08-20T13:25:08Z-
dc.date.issued2020
dc.identifier.citationPLOS ONE, v.15, n.3, article ID e0230058, 16p, 2020
dc.identifier.issn1932-6203
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/36968-
dc.description.abstractObjective To analyze factors associated with knowledge gaps and acquisition about HPV and its vaccine among medical students. Method Cross-sectional and analytical study conducted at the University of Sao Paulo Medicine School, in 2016. A convenience sample of students completed a data collection instrument containing questions on knowledge about HPV and its vaccine, and vaccine acceptability. The level of knowledge and acceptability established as a ""good level"" was 80% of correct answers on the questionnaire. Internal validity was calculated with Cronbach's alpha value (alpha) = 0.74. Bivariate and multiple analyzes were performed using the Stata (R) program (Stata Corp, College Station, USA) 14.0. Results To evaluate the internal consistency of the instrument applied, the Cronbach's alpha equation was used, obtaining the alpha value (alpha) = 0.74 for this population. This value attests that the consistency of the answers obtained with this questionnaire is considered substantial and acceptable. Among the 518 medical students who completed the survey, the majority were men 312 (60.4%) with a mean age of 23 (+/- 2.8) years old; 199 (38.3%) of the students were in the final years of graduation (5th and 6th years). Students in the first, second and third year of study had a 51% higher risk of a knowledge gap when compared to students in the final years of graduation [PR 1.51 (1.3:1.8); p < 0.001]. Men were at 22% higher risk of unsatisfactory knowledge than women are [PR 1.22 (1.07: 1.39). There was no knowledge acquisition during medical school in the following questions (p < 0.05), indication of vaccine for individuals with HIV and contraindication in pregnant patients. Conclusion Male medical students, in the first year of medical school, and those who were not vaccinated had significant knowledge gaps about HPV. The novelty of the study includes the finding of non- acquisition of knowledge during the medical school graduation on safety and vaccination schedule and vaccine administration in specific populations.eng
dc.language.isoeng
dc.publisherPUBLIC LIBRARY SCIENCEeng
dc.relation.ispartofPlos One
dc.rightsopenAccesseng
dc.subject.otherhuman-papillomavirus vaccinationeng
dc.subject.otheruniversity-studentseng
dc.subject.othercervical-cancereng
dc.subject.otherfemale studentseng
dc.subject.otherattitudeseng
dc.subject.otherawarenesseng
dc.subject.otheracceptabilityeng
dc.subject.otherinfectioneng
dc.subject.otherwomeneng
dc.subject.otherrecommendationseng
dc.titleKnowledge gaps and acquisition about HPV and its vaccine among Brazilian medical studentseng
dc.typearticleeng
dc.rights.holderCopyright PUBLIC LIBRARY SCIENCEeng
dc.identifier.doi10.1371/journal.pone.0230058
dc.identifier.pmid32191725
dc.subject.wosMultidisciplinary Scienceseng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
hcfmusp.author.externalSANTOS, Edige Felipe de Sousa:ABC Med Sch, Study Design & Sci Writing Lab, Santo Andre, SP, Brazil
hcfmusp.description.articlenumbere0230058
hcfmusp.description.issue3
hcfmusp.description.volume15
hcfmusp.origemWOS
hcfmusp.origem.idWOS:000535302300024
hcfmusp.origem.id2-s2.0-85081975084
hcfmusp.publisher.citySAN FRANCISCOeng
hcfmusp.publisher.countryUSAeng
hcfmusp.relation.referenceAgranonik M, 2011, CLIN BIOMEDICAL RES, V31eng
hcfmusp.relation.reference[Anonymous], 2019, LANCET CHILD ADOLESC, V3, P281, DOI 10.1016/S2352-4642(19)30092-6eng
hcfmusp.relation.referenceBerenson AB, 2015, HUM VACC IMMUNOTHER, V11, P1331, DOI 10.1080/21645515.2015.1022691eng
hcfmusp.relation.referenceBianco A, 2019, VACCINE, V37, P984, DOI 10.1016/j.vaccine.2018.12.062eng
hcfmusp.relation.referenceBianco A, 2014, HUM VACC IMMUNOTHER, V10, P2536, DOI 10.4161/21645515.2014.969614eng
hcfmusp.relation.referenceBowyer HL, 2013, VACCINE, V31, P1051, DOI 10.1016/j.vaccine.2012.12.038eng
hcfmusp.relation.referenceBrasil. Ministerio da Saude, 2018, 135SEI2017CGPNIDEVITeng
hcfmusp.relation.referenceBrotherton JML, 2018, BEST PRACT RES CL OB, V47, P42, DOI 10.1016/j.bpobgyn.2017.08.010eng
hcfmusp.relation.referenceBrotherton JML, 2016, MED J AUSTRALIA, V204, P184, DOI 10.5694/mja15.01038eng
hcfmusp.relation.referenceChen JM, 2016, AM INT J SOC SCI, V3, P56eng
hcfmusp.relation.referenceChernyshov PV, 2019, ACTA DERMATOVEN ALP, V28, P75, DOI 10.15570/actaapa.2019.19eng
hcfmusp.relation.referenceCinar IO, 2019, ASIA-PAC J ONCOL NU, V6, P300, DOI 10.4103/apjon.apjon_10_19eng
hcfmusp.relation.referenceD'Alessandro A, 2018, HUM VACC IMMUNOTHER, V14, P1573, DOI 10.1080/21645515.2018.1483809eng
hcfmusp.relation.referenceGilkey MB, 2016, HUM VACC IMMUNOTHER, V12, P1454, DOI 10.1080/21645515.2015.1129090eng
hcfmusp.relation.referencePereira JEG, 2019, CLINICS, V74, DOI 10.6061/clinics/2019/e1166eng
hcfmusp.relation.referenceHaverkos H, 2000, BIOMED PHARMACOTHER, V54, P54, DOI 10.1016/S0753-3322(00)88642-4eng
hcfmusp.relation.referenceHead KJ, 2013, PUBLIC HEALTH NURS, V30, P351, DOI 10.1111/phn.12044eng
hcfmusp.relation.referenceInstituto Nacional de Cancer (INCA/MS), CONTR CANC COL UT COeng
hcfmusp.relation.referenceKoc Z, 2015, J AM COLL HEALTH, V63, P13, DOI 10.1080/07448481.2014.963107eng
hcfmusp.relation.referenceKwan TTC, 2008, SEX TRANSM INFECT, V84, P227, DOI 10.1136/sti.2007.029363eng
hcfmusp.relation.referenceKwang NB, 2014, ASIAN PAC J CANCER P, V15, P9117, DOI 10.7314/APJCP.2014.15.21.9117eng
hcfmusp.relation.referenceLANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310eng
hcfmusp.relation.referenceMachalek DA, 2018, J INFECT DIS, V217, P1590, DOI 10.1093/infdis/jiy075eng
hcfmusp.relation.referenceMakwe CC, 2012, J EPIDEMIOL GLOB HEA, V2, P199, DOI 10.1016/j.jegh.2012.11.001eng
hcfmusp.relation.referenceMalo TL, 2014, CANCER EPIDEM BIOMAR, V23, P2126, DOI 10.1158/1055-9965.EPI-14-0344eng
hcfmusp.relation.referenceMarkowitz LE, 2014, MMWR RECOMM REP, V63, P1eng
hcfmusp.relation.referenceMcRee AL, 2014, J PEDIATR HEALTH CAR, V28, P541, DOI 10.1016/j.pedhc.2014.05.003eng
hcfmusp.relation.referenceNapolitano F, 2018, HUM VACC IMMUNOTHER, V14, P1558, DOI 10.1080/21645515.2018.1463943eng
hcfmusp.relation.referenceNapolitano F, 2016, HUM VACC IMMUNOTHER, V12, P1504, DOI 10.1080/21645515.2016.1156271eng
hcfmusp.relation.referenceNiccolai LM, 2015, JAMA PEDIATR, V169, P686, DOI 10.1001/jamapediatrics.2015.0310eng
hcfmusp.relation.referenceOrtashi O, 2013, VACCINE, V31, P5141, DOI 10.1016/j.vaccine.2013.08.016eng
hcfmusp.relation.referenceRajiah Kingston, 2015, VirusDisease, V26, P297, DOI 10.1007/s13337-015-0287-3eng
hcfmusp.relation.referenceRosberger Z, 2014, J CANCER EDUC, V29, P473, DOI 10.1007/s13187-013-0572-zeng
hcfmusp.relation.referenceSherman SM, 2016, J OBSTET GYNAECOL, V36, P76, DOI 10.3109/01443615.2015.1041886eng
hcfmusp.relation.referenceSilva GM, 2016, REV HUPE RIO DE JANE, V15, P328eng
hcfmusp.relation.referenceSilva SL, 2017, SAUDE SANTA MARIA, V43, P125eng
hcfmusp.relation.referenceSorpreso ICE, 2018, J HUM GROWTH DEV, V28, P5, DOI [10.7322/jhgd.143887, DOI 10.7322/JHGD.143887]eng
hcfmusp.relation.referenceSorpreso ICE, 2020, MED STUDENTS HPV KNO, DOI [10.7910/DVN/IR3UJO, DOI 10.7910/DVN/IR3UJO]eng
hcfmusp.relation.referenceSousa PDL, 2018, J HUM GROWTH DEV, V28, P58, DOI [10.7322/jhgd.143856, DOI 10.7322/JHGD.143856]eng
hcfmusp.relation.referenceUzunlar O, 2013, VACCINE, V31, P2191, DOI 10.1016/j.vaccine.2013.01.033eng
hcfmusp.relation.referenceWilliams WW, 2013, VACCINE, V31, P2937, DOI 10.1016/j.vaccine.2013.04.041eng
hcfmusp.relation.referenceWorld Health Organization, 2017, HUM PAP VACC WHO POSeng
hcfmusp.relation.referenceWorld Health Organization (WHO), 2017, CANC DIAGN SCREEN CE, V92, P241eng
hcfmusp.relation.referenceYam Pui Woo Angela, 2017, Asian Pac J Cancer Prev, V18, P1689eng
hcfmusp.relation.referenceYoruk S, 2016, BMC WOMENS HEALTH, V16, DOI 10.1186/s12905-016-0330-6eng
hcfmusp.relation.referenceZouheir Y, 2016, J PEDIATR ADOL GYNEC, V29, P292, DOI 10.1016/j.jpag.2015.11.002eng
dc.description.indexMEDLINEeng
hcfmusp.citation.scopus5-
hcfmusp.scopus.lastupdate2022-07-08-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MOG
Departamento de Obstetrícia e Ginecologia - FM/MOG

Artigos e Materiais de Revistas Científicas - FM/MPR
Departamento de Medicina Preventiva - FM/MPR

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - LIM/38
LIM/38 - Laboratório de Epidemiologia e Imunobiologia

Artigos e Materiais de Revistas Científicas - LIM/58
LIM/58 - Laboratório de Ginecologia Estrutural e Molecular

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar


Files in This Item:
File Description SizeFormat 
art_COSTA_Knowledge_gaps_and_acquisition_about_HPV_and_its_2020.PDFpublishedVersion (English)632.31 kBAdobe PDFThumbnail
View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.